The Federal Trade Commission is preparing a lawsuit against three of the largest pharmacy benefit managers, after the agency released a report alleging the companies—which manage roughly 80% of prescriptions in the U.S.—were driving up the prices of some medications, like insulin, while pushing customers away from cheaper alternatives.
The agency released a report alleging how pharmacy benefit managers drive up the costs of some ... [+]
The FTC’s lawsuit will challenge the business practices of UnitedHealth Group’s OptumRx, Cigna Group’s Express Scripts and CVS Health’s Caremark, three of the largest firms responsible for negotiating the terms and conditions for access to prescription drugs, people familiar with the matter told The Wall Street Journal.
This is a developing story and will be updated.
Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you'll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here